Gubernacular development in Mullerian inhibiting substance receptor-deficient mice

被引:12
作者
Bartlett, JE
Lee, SMY
Mishina, Y
Behringer, RR
Yang, N
Wolf, J
Temelcos, C
Hutson, JM
机构
[1] Murdoch Childrens Res Inst, F Douglas Stephens Surg Res Lab, Melbourne, Vic, Australia
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA
关键词
gubernaculum; testicular descent; Mullerian inhibiting substance;
D O I
10.1046/j.1464-410X.2002.02530.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine, in mice with disrupted Mullerian inhibiting substance (MIS;) receptor genes, whether MIS affects gubernacular development; MIS causes Mullerian duct regression and is proposed to be involved in the first stage of testicular descent, because gubernacular development is abnormal in humans with persistent Mullerian duct syndrome. Materials and methods Ten wild-type, 11 heterozygotic and 12 homozygotic mice for MIS receptor mutations were killed at 17.5 or 18.5 days after conception or at birth, to provide serial sagittal sections of the pelvis. The amount of cremaster muscle, mitotic bodies in the gubernacular bulb, and gubernacular size were quantified by computer analysis (four mice/group). Results Mullerian ducts were present in the homozygous mutants, partially present in the heterozygotes and absent in the wild-type controls. All mice had descended testes. The cremaster muscle was significantly less developed in homozygous mutants than in wild-type controls (P<0.001) and heterozygotes (P<0.01) at birth. The mitotic index between the gubernacula of all groups was indistinguishable. There was no statistical difference in gubernacular area amongst the groups. Poor cremaster muscle development in homozygous mutants gave the muscle a loose mesenchymal appearance. Conclusions Although there was an observable effect on cremaster muscle development in these mutant mice, gubernacular development and testicular descent were otherwise normal, and thus there must be other reasons for the observed differences in humans with persistent Mullerian duct syndrome.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 23 条
[11]  
HUTSON JM, 1987, PEDIATR SURG INT, V2, P191
[12]   Clinical aspects and molecular genetics of the persistent Mullerian duct syndrome [J].
Josso, N ;
Picard, JY ;
Imbeaud, S ;
diClemente, N ;
Rey, R .
CLINICAL ENDOCRINOLOGY, 1997, 47 (02) :137-144
[13]  
JOSSO N, 1993, RECENT PROG HORM RES, V48, P1
[14]   New insights into Mullerian inhibiting substance and its mechanism of action [J].
Lane, AH ;
Donahoe, PK .
JOURNAL OF ENDOCRINOLOGY, 1998, 158 (01) :1-6
[15]   MULLERIAN INHIBITING SUBSTANCE - A GONADAL HORMONE WITH MULTIPLE FUNCTIONS [J].
LEE, MM ;
DONAHOE, PK .
ENDOCRINE REVIEWS, 1993, 14 (02) :152-164
[16]  
Levy JB, 1995, J ANDROL, V16, P459
[17]   Genetic analysis of the INSL3 gene in patients with maldescent of the testis [J].
Lim, HN ;
Rajpert-De Meyts, E ;
Skakkebæk, NE ;
Hawkins, JR ;
Hughes, IA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (02) :129-137
[18]   Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation [J].
Mishina, Y ;
Rey, R ;
Finegold, MJ ;
Matzuk, MM ;
Josso, N ;
Cate, RL ;
Behringer, RR .
GENES & DEVELOPMENT, 1996, 10 (20) :2577-2587
[19]   Cryptorchidism in mice mutant for Insl3 [J].
Nef, S ;
Parada, LF .
NATURE GENETICS, 1999, 22 (03) :295-299
[20]  
PEPINSKY RB, 1988, J BIOL CHEM, V263, P18961